Keith Orford
2020
In 2020, Keith Orford earned a total compensation of $1.4M as Chief Medical Officer at Calithera Biosciences, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $149,371 |
|---|---|
| Option Awards | $772,366 |
| Salary | $455,400 |
| Other | $24,262 |
| Total | $1,401,399 |
Orford received $772.4K in option awards, accounting for 55% of the total pay in 2020.
Orford also received $149.4K in bonus, $455.4K in salary and $24.3K in other compensation.
Rankings
In 2020, Keith Orford's compensation ranked 7,143rd out of 13,090 executives tracked by ExecPay. In other words, Orford earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,143 out of 13,090 | 45th |
Division Manufacturing | 2,986 out of 5,621 | 47th |
Major group Chemicals And Allied Products | 1,204 out of 2,254 | 47th |
Industry group Drugs | 1,037 out of 1,954 | 47th |
Industry Pharmaceutical Preparations | 773 out of 1,459 | 47th |
Source: SEC filing on April 23, 2021.
Orford's colleagues
We found two more compensation records of executives who worked with Keith Orford at Calithera Biosciences in 2020.